Dr. Tony Ricco

Tony Ricco received BS and PhD degrees in chemistry from UC Berkeley and MIT, respectively. He’s held positions at Sandia National Laboratories, the University of Heidelberg, ACLARA BioSciences, the Biomedical Diagnostics Institute (Dublin), Stanford University, and NASA Ames Research Center. His R&D experience includes chemical microsensors and microsystems; polymer microfluidic systems for biotech research and pathogen detection; point-of-care medical diagnostic devices; integrated autonomous bioanalytical systems for space biology and astrobiology studies aboard small satellites; and search-for life analytical payloads for missions to the icy worlds of the solar system.

Dr. Nathan Bramall
Nathan Bramall is CEO of Leiden Measurement Technologies.

Dr. Don Arnold

Dr. Don Arnold received his B.A. in Chemistry from Cornell University and his Ph. D. from the University of California at Berkeley, studying chemical reaction dynamics and molecular spectroscopy. He completed post-doctoral studies at the University of Southern California with Professor Curt Wittig and Professor Hanna Reisler, studying molecule-surface scattering dynamics. In 1997, Don accepted a Senior Technical Staff position at Sandia National Laboratories, where he changed his focus to the development of microfluidics and microscale chemical analysis systems. In May 2000, Don co-founded a spin-out company based on this technology, Eksigent Technologies. Don led Eksigent’s microfluidic technology development effort, included winning an Advanced Technologies Program grant, developing key electrokinetic flow control technologies and managing Eksigent’s intellectual property portfolio. In 2007, Don became VP of Business Development and Strategic Alliances and played a key role in the sale of the analytical instruments portion of the business to AB SCIEX in Feb 2010. In August 2010, he led the Eksigent division of AB SCIEX as General Manager until August 2012, when he became VP of R&D and Principal Scientist in AB SCIEX. Don transitioned to Business Development in 2015 identifying and cultivating external technologies showing potential for the SCIEX pipeline. In 2017, Don founded Veristad, LLC where he is CEO and provides expert technical and business consulting for life science companies, assisting established companies during assessment of early-stage technologies and assisting early-stage technology companies as the navigate from start-up to exit. He has over 50 publications and patents and has made numerous presentations at national and international scientific conferences and universities.